Role of an anti-gastrin vaccine (PAS) alone and in combination with a PD-1 antibody on growth and metastases of gastric cancer

被引：0
|
作者：
Smith, Jill P.
Cao, Hong
Chen, Wenqiang
Mahmood, Kanwal
Phillips, Teresa
Sutton, Lynda Youngpeter
Cato, Allen
机构：
[1] Georgetown Univ, Dept Med, Washington, DC 20007 USA
[2] Georgetown Univ, Washington, DC 20007 USA
[3] Canc Adv Inc, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.334
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
334
引用
收藏
页数：3
相关论文
共 50 条
  • [41] A novel anti-LAG-3/TIGIT bispecific antibody exhibits potent anti-tumor efficacy in mouse models as monotherapy or in combination with PD-1 antibody
    Dai, Tongcheng
    Sun, Hao
    Liban, Tyler
    Vicente-Suarez, Ildefonso
    Zhang, Bin
    Song, Yongping
    Jiang, Zhongxing
    Yu, Jifeng
    Sheng, Jackie
    Lv, Binhua
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [42] Synergistic efficacy of simultaneous anti-TGF-β/VEGF bispecific antibody and PD-1 blockade in cancer therapy
    Niu, Mengke
    Yi, Ming
    Wu, Yuze
    Lyu, Lijuan
    He, Qing
    Yang, Rui
    Zeng, Liang
    Shi, Jian
    Zhang, Jing
    Zhou, Pengfei
    Zhang, Tingting
    Mei, Qi
    Chu, Qian
    Wu, Kongming
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)
  • [43] Synergistic efficacy of simultaneous anti-TGF-β/VEGF bispecific antibody and PD-1 blockade in cancer therapy
    Mengke Niu
    Ming Yi
    Yuze Wu
    Lijuan Lyu
    Qing He
    Rui Yang
    Liang Zeng
    Jian Shi
    Jing Zhang
    Pengfei Zhou
    Tingting Zhang
    Qi Mei
    Qian Chu
    Kongming Wu
    Journal of Hematology & Oncology, 16
  • [44] The combination of oxaliplatin and anti-PD-1 inhibitor promotes immune cells infiltration and enhances anti-tumor effect of PD-1 blockade in bladder cancer
    Zhao, Zihan
    Liu, Siyang
    Sun, Rui
    Zhu, Wenjie
    Zhang, Yulin
    Liu, Tianyao
    Li, Tianhang
    Jiang, Ning
    Guo, Hongqian
    Yang, Rong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [45] Anti-Programmed Death Protein-1 (PD-1) Antibody Combined with Paclitaxel Exert Anti-Cancer Effect on Cervical Cancer Cells
    Zhou, Chun
    Wu, Fang
    Liang, Mengjie
    Li, Jiayi
    Shao, Yuping
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2022, 12 (08) : 1664 - 1669
  • [46] An IND-ready anti-CD4 monoclonal antibody in combination with PD-1 inhibitors for the treatment of solid tumors
    Nakano, Y.
    Price, L.
    Dubey, S. K.
    Duthoit, I.
    Cayatte, P. A.
    Kim, H.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S166 - S167
  • [47] TNFR2 blockade alone or in combination with PD-1 blockade shows therapeutic efficacy in murine cancer models.
    LaMontagne, Russell
    Case, Katie
    Tran, Lisa
    Zheng, Hui
    Yang, Michael
    Faustman, Denise
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 124 - 125
  • [48] Treating patients in advanced cancer stage with PD-1 inhibitors alone or in combination with radiation therapy-a single center analysis
    Trommer, M.
    Marnitz, S.
    Kinsky, J.
    Adams, A.
    Hellmich, M.
    Morgenthaler, J.
    Herter, J. M.
    Celik, E.
    Von Bergwelt, M.
    Schlaak, M.
    Theurich, S.
    Baues, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S29 - S30
  • [49] Neural Stem Cell Delivery of a Chimeric Orthopoxvirus in Combination with PD-1 Antibody for the Treatment of Metastatic Ovarian Cancer in Mice
    Hammad, Mohamed A. A.
    Burke, Connor
    Chen, Nanhai
    Lu, Jianming
    Fong, Yuman
    Aboody, Karen
    MOLECULAR THERAPY, 2019, 27 (04) : 127 - 128
  • [50] Efficacy and safety of LM-108, an anti-CCR8 monoclonal antibody, in combination with an anti-PD-1 antibody in patients with gastric cancer: Results from phase 1/2 studies
    Gong, Jifang
    Liu, Chang
    Yao, Jun
    Xue, Junli
    Dai, Jing
    Ji, Yinghua
    Markman, Ben
    Hiong, Alison
    Yang, Xiuli
    Zhao, Rusen
    Zheng, Yi
    Li, Qingshan
    Wu, Jun
    Barve, Minal A.
    Ariyapperuma, Mihitha Hashara
    Richardson, Gary Edward
    Qin, Xia
    Qin, Crystal Ying
    Shen, Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345